LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) (NCT06462729)
A Randomized Study of LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
🩺 Plain-English Summary (8th-Grade Level)
The objective of this study is to evaluate the safety and effectiveness of LDGraft (investigational device) compared to 100% human tissue product allograft bone (control) when applied in an ALIF procedure in the treatment of patients with lumbar degenerative disc disease (DDD).
Who can join: Review the eligibility criteria below.
Location: Orthopaedics NorthEast — Fort Wayne, Indiana
Age range: 22 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Orthopaedics NorthEast — Fort Wayne, Indiana
- Pinehurst Surgical Clinic — Pinehurst, North Carolina
- Tennessee Orthopaedic Alliance — Nashville, Tennessee
- Newcastle Private Hospital — Newcastle, New South Wales
📞 Contact the Study Coordinator
Phone: +44 (0)115 784 0041
Email: rcochrane@locatebio.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Degenerative Disc Disease
- Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft. — Worcester, Massachusetts
- P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation — Birmingham, Alabama
- Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD — Phoenix, Arizona
- Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain — Phoenix, Arizona
- Investigation of DEXA-C Anterior Cervical Interbody System — Orange, California
- Assessing Safety of Cervical Spine Fusion With NMP® — Jasper, Alabama
Explore by condition: All Degenerative Disc Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.